Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 227

1.
2.

Poor reduction of HIV-1 RNA titres in nucleoside reverse transcriptase inhibitor experienced patients treated with indinavir combination therapy.

Ball JK, Rowe T, Curran R, Irving WL, Beards GM, Sontag G, Youle M, Moyle G, Pillay D.

Sex Transm Infect. 1999 Oct;75(5):337-9.

3.

Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study.

Liuzzi G, Chirianni A, Clementi M, Bagnarelli P, Valenza A, Cataldo PT, Piazza M.

AIDS. 1996 Dec;10(14):F51-6.

PMID:
8970677
4.

Effects of reverse transcriptase inhibitor therapy on the HIV-1 viral burden in semen.

Gilliam BL, Dyer JR, Fiscus SA, Marcus C, Zhou S, Wathen L, Freimuth WW, Cohen MS, Eron JJ Jr.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 May 1;15(1):54-60.

PMID:
9215655
5.

Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy.

Mayer KH, Boswell S, Goldstein R, Lo W, Xu C, Tucker L, DePasquale MP, D'Aquila R, Anderson DJ.

Clin Infect Dis. 1999 Jun;28(6):1252-9.

6.
7.

Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men.

Taylor S, van Heeswijk RP, Hoetelmans RM, Workman J, Drake SM, White DJ, Pillay D.

AIDS. 2000 Sep 8;14(13):1979-84.

PMID:
10997403
8.

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.

PMID:
11826235
9.

Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission.

Eron JJ, Vernazza PL, Johnston DM, Seillier-Moiseiwitsch F, Alcorn TM, Fiscus SA, Cohen MS.

AIDS. 1998 Oct 22;12(15):F181-9.

PMID:
9814860
10.

Reduction of viral load and immune complex load on CD4+ lymphocytes as a consequence of highly active antiretroviral treatment (HAART) in HIV-infected hemophilia patients.

Daniel V, Süsal C, Melk A, Weimer R, Kröpelin M, Zimmermann R, Huth-Kühne A, Uhle C, Opelz G.

Immunol Lett. 1999 Aug 3;69(2):283-9.

PMID:
10482364
11.
12.

Predictive factors influencing peak viral load drop in response to nucleoside reverse transcriptase inhibitors in antiretroviral-naive HIV-1-infected patients.

Vidal C, García F, Gatell JM, Leal M, Clotet B, Pumarola T, Miró JM, Mallolas J, Ruiz L, Cruceta A, Tortajada C.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Sep 1;19(1):55-60.

PMID:
9732070
13.

Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy.

García F, Plana M, Vidal C, Cruceta A, O'Brien WA, Pantaleo G, Pumarola T, Gallart T, Miró JM, Gatell JM.

AIDS. 1999 Jul 30;13(11):F79-86.

PMID:
10449278
14.

Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load.

Celum CL, Buchbinder SP, Donnell D, Douglas JM Jr, Mayer K, Koblin B, Marmor M, Bozeman S, Grant RM, Flores J, Sheppard HW.

J Infect Dis. 2001 Jan 1;183(1):23-35. Epub 2000 Dec 8.

15.

Longitudinal comparison between plasma and seminal HIV-1 viral loads during antiretroviral treatment.

Pinto Neto LF, Vieira NF, Soprani M, Cunha CB, Cabral VP, Dietze R, Ribeiro-Rodrigues R.

Rev Soc Bras Med Trop. 2003 Nov-Dec;36(6):689-94. Epub 2004 Feb 17.

16.

Virological response to protease inhibitor therapy in an HIV clinic cohort.

Staszewski S, Miller V, Sabin C, Carlebach A, Berger AM, Weidmann E, Helm EB, Hill A, Phillips A.

AIDS. 1999 Feb 25;13(3):367-73.

PMID:
10199227
17.

Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early Anti-Retroviral Therapy Study.

García F, Alonso MM, Romeu J, Knobel H, Arrizabalaga J, Ferrer E, Dalmau D, Ruiz I, Vidal F, Frances A, Segura F, Gomez-Sirvent JL, Cruceta A, Clotet B, Pumarola T, Gallart T, O'Brien WA, Miró JM, Gatell JM.

J Acquir Immune Defic Syndr. 2000 Sep 1;25(1):26-35.

PMID:
11064501
19.
20.

Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA.

Cu-Uvin S, Caliendo AM, Reinert S, Chang A, Juliano-Remollino C, Flanigan TP, Mayer KH, Carpenter CC.

AIDS. 2000 Mar 10;14(4):415-21.

PMID:
10770544
Items per page

Supplemental Content

Write to the Help Desk